ClearNote Health
@clearnotehealth.bsky.social
ClearNote Health is a cancer detection company focused on enabling people at risk for high-mortality cancers to live longer, healthier lives.
We were delighted to attend the premiere of Modì, directed by Johnny Depp and starring Al Pacino. Our team was out in force spreading awareness about the importance of early cancer detection.
Learn more about the Avantect test: www.avantect.com
Learn more about the Avantect test: www.avantect.com
November 5, 2025 at 5:10 PM
We were delighted to attend the premiere of Modì, directed by Johnny Depp and starring Al Pacino. Our team was out in force spreading awareness about the importance of early cancer detection.
Learn more about the Avantect test: www.avantect.com
Learn more about the Avantect test: www.avantect.com
Our latest blog shines a light on the SAFE-D Study, the world’s largest study focused on early detection of pancreatic cancer in people newly diagnosed with type 2 diabetes.
www.avantect.com/discover-the...
#pancreaticcancer
www.avantect.com/discover-the...
#pancreaticcancer
November 4, 2025 at 1:46 PM
Our latest blog shines a light on the SAFE-D Study, the world’s largest study focused on early detection of pancreatic cancer in people newly diagnosed with type 2 diabetes.
www.avantect.com/discover-the...
#pancreaticcancer
www.avantect.com/discover-the...
#pancreaticcancer
📢 Our CEO, Dave Mullarkey, has authored a new expert article in Technology Networks:
For Actionable Drug Information, Consider Dynamic Epigenetics Data
www.technologynetworks.com/genomics/art...
For Actionable Drug Information, Consider Dynamic Epigenetics Data
www.technologynetworks.com/genomics/art...
For Actionable Drug Information, Consider Dynamic Epigenetics Data
DNA sequencing alone misses many disease dynamics. Researchers are turning to epigenomic profiling, especially the biomarker 5hmC, to track active gene regulation through blood samples.
www.technologynetworks.com
October 22, 2025 at 8:57 PM
📢 Our CEO, Dave Mullarkey, has authored a new expert article in Technology Networks:
For Actionable Drug Information, Consider Dynamic Epigenetics Data
www.technologynetworks.com/genomics/art...
For Actionable Drug Information, Consider Dynamic Epigenetics Data
www.technologynetworks.com/genomics/art...
Don't miss us at @myesmo.bsky.social 2025!
Our team and collaborators will present new epigenomic research spanning multicancer detection, pancreatic cancer surveillance, and therapy monitoring.
#epigenomics #earlycancerdetection
Our team and collaborators will present new epigenomic research spanning multicancer detection, pancreatic cancer surveillance, and therapy monitoring.
#epigenomics #earlycancerdetection
October 15, 2025 at 12:55 AM
Don't miss us at @myesmo.bsky.social 2025!
Our team and collaborators will present new epigenomic research spanning multicancer detection, pancreatic cancer surveillance, and therapy monitoring.
#epigenomics #earlycancerdetection
Our team and collaborators will present new epigenomic research spanning multicancer detection, pancreatic cancer surveillance, and therapy monitoring.
#epigenomics #earlycancerdetection
📢 Press Release: ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test
www.clearnotehealth.com/press-releas...
www.clearnotehealth.com/press-releas...
September 25, 2025 at 10:20 AM
📢 Press Release: ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test
www.clearnotehealth.com/press-releas...
www.clearnotehealth.com/press-releas...
✨ Today is World Cancer Research Day!
Our mission to advance earlier and more accurate cancer detection is powered by a strong track record of scientific innovation and collaboration.
Learn more about our work: www.clearnotehealth.com
#cancerresearch #cancer
Our mission to advance earlier and more accurate cancer detection is powered by a strong track record of scientific innovation and collaboration.
Learn more about our work: www.clearnotehealth.com
#cancerresearch #cancer
September 24, 2025 at 7:09 PM
✨ Today is World Cancer Research Day!
Our mission to advance earlier and more accurate cancer detection is powered by a strong track record of scientific innovation and collaboration.
Learn more about our work: www.clearnotehealth.com
#cancerresearch #cancer
Our mission to advance earlier and more accurate cancer detection is powered by a strong track record of scientific innovation and collaboration.
Learn more about our work: www.clearnotehealth.com
#cancerresearch #cancer
Our incredible Vice President of Laboratory Operations, Shimul Chowdhury, PhD, FACMG, recently shared a personal reflection on a career dedicated to early detection - from rapid sequencing in newborns to helping build ClearNote’s clinical lab.
www.linkedin.com/pulse/era-ge...
#cancer
www.linkedin.com/pulse/era-ge...
#cancer
September 11, 2025 at 1:12 PM
Our incredible Vice President of Laboratory Operations, Shimul Chowdhury, PhD, FACMG, recently shared a personal reflection on a career dedicated to early detection - from rapid sequencing in newborns to helping build ClearNote’s clinical lab.
www.linkedin.com/pulse/era-ge...
#cancer
www.linkedin.com/pulse/era-ge...
#cancer
Proud to be an expertise partner of the 15th World CB & CDx Summit Sept 22-25 | Boston, MA
Meet our team at Booth #16 and discover how ClearNote Health's Virtuoso Platform is empowering more efficient oncology #drugdiscovery and development.
👉 Schedule a meeting: partnering@clearnotehealth.com
Meet our team at Booth #16 and discover how ClearNote Health's Virtuoso Platform is empowering more efficient oncology #drugdiscovery and development.
👉 Schedule a meeting: partnering@clearnotehealth.com
August 25, 2025 at 10:19 AM
Proud to be an expertise partner of the 15th World CB & CDx Summit Sept 22-25 | Boston, MA
Meet our team at Booth #16 and discover how ClearNote Health's Virtuoso Platform is empowering more efficient oncology #drugdiscovery and development.
👉 Schedule a meeting: partnering@clearnotehealth.com
Meet our team at Booth #16 and discover how ClearNote Health's Virtuoso Platform is empowering more efficient oncology #drugdiscovery and development.
👉 Schedule a meeting: partnering@clearnotehealth.com
📢 Don’t miss our presentation at the 17th Annual Next Generation Summit, Aug 18-20, Washington, D.C.
Talk Title: Epigenomic Signals Enable Early Cancer Detection in Liquid Biopsies
When: Monday, August 18 – 9:00 am
Presenter: Anna Bergamaschi, PhD, Vice President Product R&D, ClearNote Health
Talk Title: Epigenomic Signals Enable Early Cancer Detection in Liquid Biopsies
When: Monday, August 18 – 9:00 am
Presenter: Anna Bergamaschi, PhD, Vice President Product R&D, ClearNote Health
July 29, 2025 at 10:19 AM
📢 Don’t miss our presentation at the 17th Annual Next Generation Summit, Aug 18-20, Washington, D.C.
Talk Title: Epigenomic Signals Enable Early Cancer Detection in Liquid Biopsies
When: Monday, August 18 – 9:00 am
Presenter: Anna Bergamaschi, PhD, Vice President Product R&D, ClearNote Health
Talk Title: Epigenomic Signals Enable Early Cancer Detection in Liquid Biopsies
When: Monday, August 18 – 9:00 am
Presenter: Anna Bergamaschi, PhD, Vice President Product R&D, ClearNote Health
According to a review recently published in #JAMA, gastrointestinal cancers have become the fastest-growing type of cancers diagnosed in adults younger than 50 in the U.S.
Read the article here: www.nbcnews.com/health/healt...
Read the article here: www.nbcnews.com/health/healt...
Gastrointestinal cancers are rising dramatically in people under 50
Some researchers suspect the trend has to do with obesity and diet. Others point to changes in the gut microbiome.
www.nbcnews.com
July 21, 2025 at 1:40 PM
According to a review recently published in #JAMA, gastrointestinal cancers have become the fastest-growing type of cancers diagnosed in adults younger than 50 in the U.S.
Read the article here: www.nbcnews.com/health/healt...
Read the article here: www.nbcnews.com/health/healt...
📢 We are happy to announce that ClearNote Health has received UK Conformity Assessed (UKCA) marking for its Avantect® Pancreatic Cancer Test.
www.clearnotehealth.com/press-releas...
www.clearnotehealth.com/press-releas...
July 9, 2025 at 12:28 PM
📢 We are happy to announce that ClearNote Health has received UK Conformity Assessed (UKCA) marking for its Avantect® Pancreatic Cancer Test.
www.clearnotehealth.com/press-releas...
www.clearnotehealth.com/press-releas...
📢 Press Release: ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients
With up to 15,000 patient participants, it will be the largest study of its kind!
www.clearnotehealth.com/press-releas...
#pancreaticcancer
With up to 15,000 patient participants, it will be the largest study of its kind!
www.clearnotehealth.com/press-releas...
#pancreaticcancer
June 16, 2025 at 12:04 PM
📢 Press Release: ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients
With up to 15,000 patient participants, it will be the largest study of its kind!
www.clearnotehealth.com/press-releas...
#pancreaticcancer
With up to 15,000 patient participants, it will be the largest study of its kind!
www.clearnotehealth.com/press-releas...
#pancreaticcancer
It was a privilege to connect with so many in the oncology community at #ASCO25.
We were proud to share how our Virtuoso #epigenomics platform is redefining what’s possible for more efficient and effective #drugdevelopment.
A big thank you to everyone who attended our poster presentation.
We were proud to share how our Virtuoso #epigenomics platform is redefining what’s possible for more efficient and effective #drugdevelopment.
A big thank you to everyone who attended our poster presentation.
June 9, 2025 at 8:30 PM
It was a privilege to connect with so many in the oncology community at #ASCO25.
We were proud to share how our Virtuoso #epigenomics platform is redefining what’s possible for more efficient and effective #drugdevelopment.
A big thank you to everyone who attended our poster presentation.
We were proud to share how our Virtuoso #epigenomics platform is redefining what’s possible for more efficient and effective #drugdevelopment.
A big thank you to everyone who attended our poster presentation.
📢 Don't miss our poster presentation at @ascocancer.bsky.social 2025
#ASCO25 #cancerbiology #epigenomics
#ASCO25 #cancerbiology #epigenomics
May 23, 2025 at 4:17 PM
📢 Don't miss our poster presentation at @ascocancer.bsky.social 2025
#ASCO25 #cancerbiology #epigenomics
#ASCO25 #cancerbiology #epigenomics
In a recently published article in Diagnostics World, our CEO Dave Mullarkey shares how a stepping-stone approach, starting with single-cancer tests targeting high-mortality cancers, can lay the groundwork for broad, multi-cancer early detection.
www.diagnosticsworldnews.com/news/2025/05...
#MCED
www.diagnosticsworldnews.com/news/2025/05...
#MCED
May 8, 2025 at 7:23 PM
In a recently published article in Diagnostics World, our CEO Dave Mullarkey shares how a stepping-stone approach, starting with single-cancer tests targeting high-mortality cancers, can lay the groundwork for broad, multi-cancer early detection.
www.diagnosticsworldnews.com/news/2025/05...
#MCED
www.diagnosticsworldnews.com/news/2025/05...
#MCED
📢 Press Release: Human Longevity, Inc., Expands Cancer Prevention Offering by Selecting the ClearNote Health Avantect® Early Detection #PancreaticCancer Test.
www.prnewswire.com/news-release...
www.prnewswire.com/news-release...
May 6, 2025 at 12:16 PM
📢 Press Release: Human Longevity, Inc., Expands Cancer Prevention Offering by Selecting the ClearNote Health Avantect® Early Detection #PancreaticCancer Test.
www.prnewswire.com/news-release...
www.prnewswire.com/news-release...
Meet Our Chief Scientific Officer, Dr. Sam Levy, at #DDW25!
Speak with Dr. Levy at our booth to learn how ClearNote Health is harnessing the power of the epigenome to drive early #pancreaticcancer detection and transform patient outcomes.
📍 Location: Booth 5525
📅 When: May 4th & 5th, 12:00-2:00pm
Speak with Dr. Levy at our booth to learn how ClearNote Health is harnessing the power of the epigenome to drive early #pancreaticcancer detection and transform patient outcomes.
📍 Location: Booth 5525
📅 When: May 4th & 5th, 12:00-2:00pm
May 2, 2025 at 5:22 PM
Meet Our Chief Scientific Officer, Dr. Sam Levy, at #DDW25!
Speak with Dr. Levy at our booth to learn how ClearNote Health is harnessing the power of the epigenome to drive early #pancreaticcancer detection and transform patient outcomes.
📍 Location: Booth 5525
📅 When: May 4th & 5th, 12:00-2:00pm
Speak with Dr. Levy at our booth to learn how ClearNote Health is harnessing the power of the epigenome to drive early #pancreaticcancer detection and transform patient outcomes.
📍 Location: Booth 5525
📅 When: May 4th & 5th, 12:00-2:00pm
Join ClearNote Health at Digestive Disease Week (#DDW) in San Diego May 406, where we’ll be showcasing the #Avantect Pancreatic Cancer Test - a groundbreaking epigenomic liquid biopsy designed to aid in the early detection of pancreatic cancer.
Visit us at booth 5525
Visit us at booth 5525
April 29, 2025 at 6:26 PM
Join ClearNote Health at Digestive Disease Week (#DDW) in San Diego May 406, where we’ll be showcasing the #Avantect Pancreatic Cancer Test - a groundbreaking epigenomic liquid biopsy designed to aid in the early detection of pancreatic cancer.
Visit us at booth 5525
Visit us at booth 5525
Last week, we proudly celebrated National Medical Laboratory Professionals Week at ClearNote Health! 🎉
A huge thank you to our tremendous laboratory team for their on-going commitment and dedication to our mission of saving lives through earlier detection of cancer.
#LabWeek
A huge thank you to our tremendous laboratory team for their on-going commitment and dedication to our mission of saving lives through earlier detection of cancer.
#LabWeek
April 28, 2025 at 12:58 PM
Last week, we proudly celebrated National Medical Laboratory Professionals Week at ClearNote Health! 🎉
A huge thank you to our tremendous laboratory team for their on-going commitment and dedication to our mission of saving lives through earlier detection of cancer.
#LabWeek
A huge thank you to our tremendous laboratory team for their on-going commitment and dedication to our mission of saving lives through earlier detection of cancer.
#LabWeek
ClearNote Health will be showcasing the latest advancements in tumor subtyping and circulating tumor fraction technologies at the @theaacr.bsky.social Annual Meeting 2025.
Learn more: www.clearnotehealth.com/press-releas...
#epigenomics #drugdevelopment
Learn more: www.clearnotehealth.com/press-releas...
#epigenomics #drugdevelopment
ClearNote Health to Showcase Latest Advancements in Tumor Subtyping and Circulating Tumor Fraction Technologies at AACR Annual Meeting 2025 - ClearNote Health
Read about our lineup of presentations at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago taking place April 25-30, 2025. Meeting attendees can learn about ...
www.clearnotehealth.com
April 23, 2025 at 12:14 PM
ClearNote Health will be showcasing the latest advancements in tumor subtyping and circulating tumor fraction technologies at the @theaacr.bsky.social Annual Meeting 2025.
Learn more: www.clearnotehealth.com/press-releas...
#epigenomics #drugdevelopment
Learn more: www.clearnotehealth.com/press-releas...
#epigenomics #drugdevelopment
📢 We will be at the @theaacr.bsky.social Annual Meeting '25, 25-30/04, Chicago.
Discover how our Virtuoso Epigenomics Platform is empowering more efficient oncology #drugdiscovery & development by leveraging 5hmC #epigenomic profiling to uncover active cancer biology patterns from #cfDNA in plasma.
Discover how our Virtuoso Epigenomics Platform is empowering more efficient oncology #drugdiscovery & development by leveraging 5hmC #epigenomic profiling to uncover active cancer biology patterns from #cfDNA in plasma.
April 9, 2025 at 7:28 AM
📢 We will be at the @theaacr.bsky.social Annual Meeting '25, 25-30/04, Chicago.
Discover how our Virtuoso Epigenomics Platform is empowering more efficient oncology #drugdiscovery & development by leveraging 5hmC #epigenomic profiling to uncover active cancer biology patterns from #cfDNA in plasma.
Discover how our Virtuoso Epigenomics Platform is empowering more efficient oncology #drugdiscovery & development by leveraging 5hmC #epigenomic profiling to uncover active cancer biology patterns from #cfDNA in plasma.